On December 6, 2017 NovMetaPharma Co., Ltd. (XKON:A229500) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,970 KRW | +3.72% | -4.52% | -66.00% |
1st Jan change | Capi. | |
---|---|---|
-66.00% | 45.33M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- A229500 Stock
- News NovMetaPharma Co., Ltd.
- NovMetaPharma Co., Ltd. announced that it has received KRW 10.22 billion in funding from KMH Co. Ltd., Whale Investment and other investors